Oscar Health (OSCR) Sees Significant ETF Selling on Friday
ETF activities showed a notable trend in Oscar Health's stock, with significant net selling recorded on Friday.
On Friday, Oscar Health (OSCR) experienced a substantial net selling of $38.8 million in ETF trades. Despite the selling pressure, a total of 10 ETFs opted to buy shares, albeit in smaller amounts compared to the single ETF that sold.
Notable Selling Activity
The primary force behind the net selling was the AVUV ETF, which significantly reduced its holdings by 1,266,137 shares, translating to a decrease in value of approximately $39.2 million. After the adjustment, AVUV retained 4,664,000 shares, now making up 0.45% of its portfolio.
In contrast, other ETFs like IWM added a mere 9,048 shares valued at around $0.3 million. Meanwhile, the transactions for IUS, PRFZ, BBSC, and DFAU accounted for minimal dollar changes in relation to their holdings.
ETF Trades Overview
- AVUV: -1,266,137 shares, -$39.2M
- IUS: +44 shares, $0.0M
- PRFZ: +203 shares, $0.0M
- BBSC: +415 shares, $0.31%
- DFAU: +435 shares, $0.01%
- IWM: +9,048 shares, $0.3M
Recent Trends in ETF Activity
In examining the trades over recent days, it appears that Oscar Health has been caught in a wave of selling. Out of the last five trading days, two showed net buying while three indicated net selling. This trend suggests an overall decrease in investment interest from ETFs related to this stock.
ETF Selling Trends
- Oct 23: -$38.8M (10 buyers, 1 seller)
- Oct 22: +$2.0M (18 buyers, 2 sellers)
- Oct 21: -$0.8M (3 buyers)
- Oct 20: +$0.5M (8 buyers)
- Oct 19: -$3.1M (7 buyers)
About Oscar Health
Oscar Health Inc. is focused on the health insurance arena, primarily catering to individuals and families in the United States. The company sells health plans both through state and federal Affordable Care Act (ACA) marketplaces and directly to consumers, as well as offering plans for small groups and Medicare Advantage.
In its recent financial disclosures, Oscar Health reported revenue of $15.32 billion for the trailing twelve months, surpassing the previous year by 23.0%. The company has managed to maintain a net margin of 3.6%.
Key Financial Metrics
Oscar's stock currently trades at a P/E ratio of 22.72, a P/B ratio of 4.68, and a P/S ratio of 0.62. With a market capitalization of $9.6 billion, Oscar's GF Score stands at 82, suggesting it holds a fair market value of $24.88, which is below its trading price of $31.10. Remarkably, the stock has delivered impressive returns of 116.42% year-to-date.
Quick Take on OSCR
- Current Price: $31.10
- Market Cap: $9.60B
- Revenue (Last 12 Months): $15.32B
- Revenue Growth: +23.0%
- Net Margin: 3.6%
- P/E: 22.72
- P/B: 4.68
- P/S: 0.62
- GF Score: 82/100
- GF Value: $24.88
- Year-to-Date Return: +116.42%